Related Experiment Video
Updated: Aug 7, 2026
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
Gene Replacement Strategies for Lung Cancer
1Molecular Thoracic Oncology, UT M.D. Anderson Cancer Center, Houston, TX, USA
Abstract:
Advances in our understanding of the molecular genetics of cancer present an opportunity to develop prevention and treatment strategies based on the reversal of specific genetic lesions. This strategy is analogous to the classic concept of gene therapy for replacement of defective or nonfunctioning genes. The gene families implicated in carcinogenesis include dominant oncogenes and tumor suppressor genes. Regional administration of viral vectors expressing wildtype p53 and antisense K-ras prevents tumor growth for tumors with the specific genetic lesions in orthotopic tumor models and mediates regression of large established tumors. These studies provide a rationale for a new clinical protocol recently approved by the National Institutes of Health Recombinant DNA Advisory Committee and Food and Drug Administration to replace a defective p53 gene with intratumor injection of recombinant retrovirus expressing wild-type p53 or elimination of activated K-ras by expression of antisense K-ras messenger RNA. If these agents are efficacious, their lack of toxicity may provide a sufficiently high therapeutic index such that they could be used as an adjuvant to surgery to treat patients with earlier stages of cancer or as prevention for second primary cancers for individuals with genetic abnormalities in premalignant lesions. Although much research needs to be done, the possibility of specific gene targeting with a high therapeutic index makes this a promising area of investigation.
Insights
Gene therapy offers new cancer treatment strategies by correcting genetic defects. Viral vectors delivering wild-type p53 or antisense K-ras show promise in preventing and regressing tumors.
Area of Science:
- Oncology
- Molecular Genetics
- Gene Therapy
Background:
- Cancer development involves genetic mutations in oncogenes and tumor suppressor genes.
- Gene therapy offers a strategy to reverse specific genetic lesions for cancer treatment.
- Understanding cancer's molecular genetics enables targeted prevention and therapeutic approaches.
Purpose of the Study:
- To investigate the potential of gene therapy for cancer treatment by targeting specific genetic mutations.
- To evaluate the efficacy of viral vectors expressing wild-type p53 and antisense K-ras in preclinical cancer models.
- To provide a rationale for clinical trials involving gene replacement and gene silencing strategies for cancer.
Main Methods:
- Utilizing orthotopic tumor models to assess the effects of gene therapy.
- Employing viral vectors for regional administration of therapeutic genes (wild-type p53, antisense K-ras).
- Developing and obtaining approval for clinical protocols involving gene therapy for cancer treatment.
Main Results:
- Regional administration of viral vectors expressing wild-type p53 and antisense K-ras prevented tumor growth in relevant genetic models.
- Established tumors demonstrated regression following treatment with these gene therapy agents.
- The potential for a high therapeutic index due to low toxicity was observed.
Conclusions:
- Gene therapy targeting specific genetic lesions, such as those involving p53 and K-ras, shows significant promise for cancer treatment.
- These findings support the clinical application of gene therapy as an adjuvant to surgery or for cancer prevention.
- Further research is warranted to fully explore the therapeutic potential of targeted gene manipulation in oncology.
Related Concept Videos
01:16In-vitro Mutagenesis
00:59Gene Therapy